Amgen, Ilypsa Spin Out Relypsa To Further Cardiovascular, Renal Pipeline

Privately-held biopharma will have a pipeline of potassium binder drug candidates in early development.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet